These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3665210)

  • 21. [Digoxon or digitoxin in patients with terminal kidney insufficiency in the dialysis stage?].
    Risler T; Peters U; Grabensee B; Fritsch WP; Hausamen TU; Grosse-Brockhoff F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1662-4. PubMed ID: 611905
    [No Abstract]   [Full Text] [Related]  

  • 22. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
    Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
    J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined liquid chromatography/radioimmunoassay with improved specificity for serum digoxin.
    Gault MH; Longerich L; Dawe M; Vasdev SC
    Clin Chem; 1985 Aug; 31(8):1272-7. PubMed ID: 4017230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacokinetics of beta-methyldigoxin in patients with chronic renal failure treated with extracorporeal dialysis].
    Baczyński R; Kokot F; Johnen R
    Pol Arch Med Wewn; 1977 Sep; 58(3):213-21. PubMed ID: 928160
    [No Abstract]   [Full Text] [Related]  

  • 25. [Letter: Kinetics of elimination and dosage of digoxin in patients with kidney failure].
    Risler T
    Dtsch Med Wochenschr; 1974 Oct; 99(42):2130-1. PubMed ID: 4426236
    [No Abstract]   [Full Text] [Related]  

  • 26. Endogenous digoxin-immunoactive factor in human subjects.
    Valdes R
    Fed Proc; 1985 Sep; 44(12):2800-5. PubMed ID: 3839758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased volume of distribution of digoxin in a patient with renal failure.
    Szefler SJ; Jusko WJ
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1095-8. PubMed ID: 4760884
    [No Abstract]   [Full Text] [Related]  

  • 28. Anomalous serum digoxin concentrations in patients with hepatic or renal dysfunction.
    Frewin DB; Marmanidis H; Lehmann DR; Morris RG
    Aust N Z J Med; 1986 Apr; 16(2):241-3. PubMed ID: 3463280
    [No Abstract]   [Full Text] [Related]  

  • 29. [Digoxin dosage in patients with kidney insufficiency].
    Gustorf HG; Saborowski F; Caesar K; Hossmann V
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1660-1. PubMed ID: 611904
    [No Abstract]   [Full Text] [Related]  

  • 30. [Protein binding and hydroxylation rate of digitoxin in renal failure].
    Kuhlmann J; Pabst J
    Dtsch Med Wochenschr; 1982 Oct; 107(41):1551-5. PubMed ID: 7128466
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of MDRD equation to detect occult renal failure and reduce the risk of digitalis overdose].
    Cepeda Piorno J; Pobes Martínez de Salinas A; González García ME; Fernández Rodríguez E
    Nefrologia; 2009; 29(2):150-5. PubMed ID: 19396321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radioimmunological determination of digitalis in the blood during treatment with beta-methyldigoxin in patients with different degrees of renal function].
    Gobbi A; Tabacchi GC; Giangrande A; Crespi G
    Minerva Cardioangiol; 1980 Jun; 28(6):445-51. PubMed ID: 7242930
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clearance of digoxin in persons with healthy kidneys and in patients with reduced renal function].
    Risler T; Grabensee B; Hausamen TU; Schröder E; Grosse-Brockhoff F
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():306-8. PubMed ID: 4450674
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on hyperglucagonemia in renal failure].
    Oka H
    Fukuoka Igaku Zasshi; 1987 Jul; 78(7):402-13. PubMed ID: 3679060
    [No Abstract]   [Full Text] [Related]  

  • 35. [The clinical significnce of serum digoxin assay].
    Iisalo E; Sundqvist H
    Duodecim; 1972; 88(9):630-8. PubMed ID: 5020850
    [No Abstract]   [Full Text] [Related]  

  • 36. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: are they related?
    Malyszko J; Malyszko J; Wolczynski S; Mysliwiec M
    Nephrol Dial Transplant; 2006 Jan; 21(1):145-52. PubMed ID: 16141459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Digoxin level as a limited drug toxicity indicator in the assessment of post-digitalis arrhythmia].
    Sinkiewicz W; Marzec A; Jankowski A; Hoffmann A
    Wiad Lek; 1994; 47(21-24):808-12. PubMed ID: 8999691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interference of digoxin like immunoreactive substances with four recent reagents for digoxin determination].
    Marzullo C; Bourderont D; Dorr R
    Ann Biol Clin (Paris); 1996; 54(2):91-6. PubMed ID: 8763633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.
    O'Riordan JL; Page J; Kerr DN; Walls J; Moorhead J; Crockett RE; Franz H; Ritz E
    Q J Med; 1970 Jul; 39(155):359-76. PubMed ID: 5478506
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.